CGM
+5
/
Oct 17, 2025
We tried the Libre 3 Plus continuous glucose monitor for a month and dive into its features, smartphone app, alerts, accuracy and more.
News
+2
Oct 15, 2025
The move to end research into a potential type 1 diabetes cure has left many people with diabetes frustrated, reflective, and still holding on to hope.
+3
Oct 14, 2025
The FDA has accepted MannKind’s application to expand the use of its inhaled insulin, Afrezza, to children, marking a key step toward potential pediatric approval.
Oct 7, 2025
Roche’s latest integration brings AI-driven glucose predictions, personalized logging, and easy data sharing into one connected platform.
Podcast
+1
Aug 18, 2025
From AI-powered care to breakthroughs in pumps and cures, this year’s conference proved diabetes education is more essential than ever.
Research
Aug 11, 2025
Medications like Ozempic, Wegovy, and Mounjaro are showing promising results for people with type 1 diabetes — but they’re still not approved for this use.
May 8, 2023
I sat down with my diabetes educator Mary Rose to talk about early diagnosis, support, and finding strength in the journey.
